c u l t u r e modulation o f EGFR e x p r e s s i o n by hormones s u c h in all European countrics \\as IDDM ~ncldcncc cvaluatcd and thc mcthwJolog! \\as so a s p a r a t h y r o i d -r e l a t e d p e p t i d e a n d r e t i n o i c a c i d o r toxic diflerent that it d~d not allon, for a strict cornpurlson This \\as thc alm of the Eurodiab s u b s t a n c e s s u c h a s smoke d e r l v e d p r o d u c t s i n t e r f e r e s with ACE program. a concerted action by thc Europcan Commun~ty. to mcasurc IDDM p l a c e n t a l endocrine f u n c t I o n s . I n t e r e s t i n~l y , i n m i c r o v i l l l inctdence rates in children (0-l4)r) with a common. prospective and cshausttve p u r i f i e d from p l a c e n t a o f I n t r a u t e r i n e g r o w t h retardation protocol over 2 )cars (1989-HI) w allo\\-for comparl\ons bet\\cen geographical area. (IUGR) a d e c r e a s e o r a b s e n c e o f t h e EGFR t y r o s l n e k l n a s e More than 15 countrics are ~nvolvcd in the projcct and thc rcsults dcmonstmtc largc a c t i v l t y i s o b s e r v e d . T h l s c a n b e r e l a t e d t o a d e c r e a s e (tenfold) \,arialions in incidence ratcs across Europc: Finland ma~ntains thc h~ghcst rate i n EGFR e x p r e s s i o n I n p l a c e n t a w i t h IUGR re'ated t o \vorld\vide (=40/10~1~r). folio\\-cd by the othcr Nordic countrlcs. Thcrc is a trend for materna1 toxemia.
I n some placentas with I d i o p a t h i c IUGR the rates to decrease from north to south. but alho from \\cat to cast: Grccce and a t r u n c a t e d f o r m o f EGFR l a c k l n g I n t y r o s l n e k l n a s e activity, i s observed, T h i s suggests t h a t a n a l t e r a t i o n Romania exhibit the lo\vest rates In Europc (<6110>~1!r). Thcrc IS thc puuling cluster o f EGFR b i o l o g i c a l a c t i v l t y m i g h t i n t e r f e r e with t h e of Sardinia in the middlc of the meditcrmncan basin 1~1th a valuc a? high as in Finland.
f e t o p l a c e n t a l u n l t d e v e l o p i n e n t . The largc numbcr of neibly diagnosed cuscs (>3(K)O) included in the ftrst phase of the Eurodiab ACE program allo\vs for a dctailcd spcofic una1)sis o f agc and seasonality. Altogether thcrc is an ovcr-rcprcscntati<m of b o~s 1s girls (BIG =1.1). The age distribution at diagnosis \\as 186. 34% and 48'3 in rhc O4)r, 5-9yr and 10-14 )r old groups rcspccti\,cl!. Thcrc is no signillcant clicct oi scx, :~gc group and Etiology, ~~~~~i~~ and ~~~i~~~~~~t~l F~~~~~~ country by thcmsclvcwn specific incidcnw ratcs, but thcrws-a significant intcraclion bctnccn age group and gcographlcal arc:l ~ndlcatirlg that incidence ratcs ior thc 0 4 and 5-9 yr groups seem to vary from countr) to country in a similar lashion but not in thc 31 pubertal agc group (10-14yr). Thc obscrvcd dart1 i <~r sc;isonal \arl:~tion fit to a sinusoidal mcxlcl with a pcak at \\~ntcrtin~c. amplitude of \\hich can ail;~rd up to 40% IMMUNOGENETICS OF TYPE I MELLITUS. M. T r u c c~, of variation and tcnds to ~ncrcasc 1~1th agc and \ \~t h thc inc~dcricc level of the countq. etiology of IDDM in ch~ldrcn assume 1010 different configurations. If IDDM is provoked by a single antigen, a restricted set of T cell clones should emerge during the destruction of the insulin producing cells. However, this phenomenon is difficult to study because T cells from the pancreas of patients with IDDM, at the onset of the disease, are required to characterize this process. We had the opportunity to study the pancreas of a newly diagnosed child with IDDM who unfortunately died of brain swelling during treatment of diabetic ketoacidosis. T cells from isolated islets were characterized f i r s t degree r e l a t i v e s of p a t i e n t s with IDDM and highly speLific prediction is possible within a small subset of t h i s population. Since around 90% of f u t u r e cases w i l l come from those who have no c l o s e r e l a t i v e with IDDM, prediction and intervention within the general population w i l l become the main p r i o r i t y f o r the f u t u r e . Risk of progression t o IDDM can be assessed by means of a decision t r e e analysis. This h i g h l i g h t s the d i f f e r e n t prognosis of markers when applied t o those with and without a family history of the d i s e a s e , and provides a l o g i c a l approach t o disease prediction. Large numbers of f i r s t degree r e l a t i v e s must be screened i n order t o r e c r u i t s u f f i c i e n t numbers of high r i s k individuals f o r prospective study o r controlled t r i a l s of intervention. This implies t h e need f o r c a r e f u l standardization and multicentre c o l l a b o r a t i v e s t u d i e s . This approach should allow new predictive markers and models t o be evaluated, and s t r a t e g i e s of intervention t o be t e s t e d , with maximum e f f i c i e n c y and minimal delay. Thc intracellular pathways by which binding of GH to its receptor elicib its diverse effecb on growth, differentiation and metabolism have eluded investigators for many years. We havc hypothcsiizd that activation by GH of a GH receptor (GHR)-associated tyrosine kinase is an important early, and perhaps, initiating step in signal uansduct~on by GH. This was suggested by initial studies showing that G H st~mulates the tyrosyl phosphorylation of the GHR and that highly purified GH-GHR complexes havc tyrosine kinase activity. These findings were consistent with GHR itself being a ligand-activatcd tyrosine kinasc like the receptors for many growth factors. However, more recent studies using cells transfected with the cloned liver GHR cDNA lead to the hypothesis that the GHR forms a complex with a non-receptor tyrosine kinase, the amount of which may vary with cell type. Expcrimenb using tmncatcd GHRs expressed in Chinese hamster ovary (CHO) and rat insulinoma (RIN) cells indicate that the kinase is likely to be a -120-kDa protein. The physiological importance of the GHR-associated kinase is attested to by experiments using and-phosphotyrosine antibodies, tyrosine kinase inhibitors, and/or truncated and mutated GHRs. The results of these experiments indicate that the GHR-associated tyrosine kinasp.: 1) is stimulated very rapidly following binding of GH to ics receptor (<30 sec); 2) is stimulated by very low GH concentrartons (0.5 ng/ml); and 3) is likely to play a role in stimulation by GH of a varlcty of cellular responses, including MAP (mitogen activated rotei in) kinasc acrivtty and c-fos gene expression. Furthcrmorc, phosphorylation of specific tyrosyl residues in GHR appears to be necessary for some responses to GH, includtng st~mulation of MAP k~nase activity. These results suggest that thc Varlatlons ~n incidcncc r:ltcs 01 IDDM havc bccn dcrurncntcd i11r the last 20 !cars in GHR-assoclatcd tyroslnc kinase has at least two roles.
he first is to wms of gc<)gr:~phical hctcrogcnc~t!. scllronaltt). :~gc :~nd sccul.~r trend. Nonc of thcsc ~hos~horylntc and thc~chy activate othcr proteins. The second is to phosphorylate vanations can 11t an explanatory mcxicl for thc ctlolog!' (11' the d l~c~\ c but s~culations tyrosyl residues in itself and Ihc GHR. These phosphory]ated tyrosines may involt ~n g "cnvironmcntal factors" -in c<)nIrL\t \\lth the gcncuc dctcrnllnants-t)rlglnatc as dock~i~g sitCs for PrOICinS in orher pathways, mlis new vision of how from thcsc observations. *hc gcogrJphlcal varIatiOns In IDDM lncldcncc 1" chlldrcn across Europe arc knoJVn "' functions lead lo lhc or new cellular actions for GH and since the '70s. They have been clarmcd to iigurc a n(,rth-south gradlent 01. incldcncc '''ereby increase our understanding of how GH regulates growth, differentiatinn along the continent. \\hcrc Flnlarld rcprc\cntcd thc top and Francc the h)ltc)m But not S8m"lmholism.
